Cost Analysis of Ganciclovir and Foscarnet in Recipients of Allogeneic Hematopoietic Cell Transplant with Cytomegalovirus Viremia

BACKGROUND: Ganciclovir (GCV) and foscarnet (FOS) are the most commonly used antivirals for preemptive treatment of cytomegalovirus (CMV) viremia in recipients of allogeneic hematopoietic cell transplantation (alloHCT). The current literature indicates similar efficacy between these agents. Thus, th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transpl Infect Dis
Main Authors: Chen, Jason, Ross, Justine Abella, Tegtmeier, Bernard, Yang, Dongyun, Ito, James I., Zaia, John A., Dickter, Jana K, Nakamura, Ryotaro, Mokhtari, Sally, Kriengkauykiat, Jane, Al Malki, Monzr M., Dadwal, Sanjeet S
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7162712/
https://ncbi.nlm.nih.gov/pubmed/31840347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13233
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker